Pregabalin
Back to searchMolecule Structure
Scientific Name
Pregabalin
Description of the Drug
Pregabalin is an anticonvulsant drug used to treat neuropathic pain conditions and fibromyalgia, and for the treatment of partial onset seizures in combination with other anticonvulsants.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00230
http://www.drugbank.ca/drugs/DB00230
Brand Name(s)
Alzain, Axalid, Lecaent, Lyrica, Lyrica cr, Pregabalin, Rewisca
Company Owner(s)
Cipla Ltd, Alkem Laboratories Ltd, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Rising Pharma Holdings Inc, Rubicon Research Private Ltd, Alvogen Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Voltage-gated calcium channel | PROTEIN COMPLEX GROUP | MODULATOR | CHEMBL2363032 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL8227 | SCHEMBL17510367 |
PharmGKB | PA164754814 | |
Human Metabolome Database | HMDB0014375 | |
DrugBank | DB00230 | |
PubChem: Thomson Pharma | 15219358 | 15171006 |
PubChem | 5486971 | 25271887 |
Mcule | MCULE-4620415947 | |
Nikkaji | J702.547E | |
BindingDB | 50164279 | |
EPA CompTox Dashboard | DTXSID1045950 | |
DrugCentral | 2255 | |
ChemicalBook | CB2251105 | |
Guide to Pharmacology | 5484 | |
rxnorm | PREGABALIN | LYRICA |
PubChem: Drugs of the Future | 12014780 | |
ChEBI | 64356 | |
ZINC | ZINC000000005152 |